The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, Sony Reader...
New to eBooks.com?Learn more
- Bestsellers - This Week
- Foreign Language Study
- Bestsellers - Last 6 months
- Graphic Books
- Health & Fitness
- Political Science
- Biography & Autobiography
- Psychology & Psychiatry
- Body Mind & Spirit
- House & Home
- Business & Economics
- Children's & Young Adult Fiction
- Juvenile Nonfiction
- Language Arts & Disciplines
- Crafts & Hobbies
- Science Fiction
- Current Events
- Literary Collections
- Literary Criticism
- Literary Fiction
- Social Science
- The Environment
- Sports & Recreation
- Family & Relationships
- Study Aids
- Folklore & Mythology
- Food and Wine
- Performing Arts
- True Crime
- Foreign Language Books
- PublicAffairs 2014; US$ 26.99
In 1950, a diagnosis of cancer was all but a death sentence. Mortality rates only got worse, and as late as 1986, an article in the New England Journal of Medicine lamented: “We are losing the war against cancer.? Cancer is one of humankind?s oldest and most persistent enemies; it has been called the existential disease. But we are now entering... more...
- Nomos Verlagsgesellschaft 2014; Not Available
Dieses Buch untersucht die Lifecycle-Management-Strategien, die von Pharma-Unternehmen eingesetzt werden, um den Wert ihres Produktportfolios zu maximieren. Solche Strategien werden manchmal von Generika-Unternehmen als ?evergreening? bezeichnet. Die Analyse erfolgt anhand zwei zufällig ausgewählter ?Blockbuster?-Medikamente, Taxotere und Xalatan... more...
Rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into accountDiplomica Verlag 2014; US$ 51.75
Biopharmaceutical medicinal products (biologics) represent a huge financial market. Thus upon patent protection expiry of the innovator (reference) biologic there is interest from industry to gain a portion of this market by launching a 'similar' biologic at a reduced development cost, thus boosting potential gains. The EMA responded to this desire... more...
- Diplomica Verlag 2014; US$ 51.75
This book deals in general with mergers and acquisitions in the CRO industry, and more specifically with reasons for M and A, success factors during the M and A process, and why M and A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new... more...
- Elsevier Science 2014; US$ 256.00
This new volume of Advances in Pharmacology presents the emerging targets and therapeutics in the treatment of psychostimulant abuse. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike. Contributions from the best authors in the field An essential... more...
- Taylor and Francis 2014; US$ 220.00
Several books on the market cover combinatorial techniques, but they offer just a limited perspective of the field, focusing on selected aspects without examining all approaches and integrated technologies. Combinatorial Chemistry and Technologies: Methods and Applications answers the demand for a complete overview of the field, covering all of the... more...
- Wiley 2014; US$ 125.00
Polymers have played a critical role in the rational design and application of drug delivery systems that increase the efficacy and reduce the toxicity of new and conventional therapeutics. Beginning with an introduction to the fundamentals of drug delivery, Engineering Polymer Systems for Improved Drug Delivery explores traditional drug delivery... more...
- Springer 2014; US$ 279.00
There are many steps on the road from discovery of an anticancer drug to securing its final approval by the Food and Drug Administration. In this thoroughly updated and expanded second edition of the Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, leading investigators synthesize an invaluable overview of the experimental and clinical... more...
- University of Chicago Press 2014; US$ 105.00
For over a century, plant specialists worldwide have sought to transform healing plants in African countries into pharmaceuticals. And for equally as long, conflicts over these medicinal plants have endured, from stolen recipes and toxic tonics to unfulfilled promises of laboratory equipment and usurped personal patents. In Bitter Roots , Abena Dove... more...
- World Health Organization 2013; US$ 39.60
WHO Drug Information communicates pharmaceutical information that is either developed and issued by WHO or transmitted to WHO by research and regulatory agencies throughout the World. The journal also includes regular presentations of newly proposed and recommended International Nonproprietary Names (INN) for Pharmaceuticals Substances. This volume... more...